טוען...
Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
BACKGROUND: Immunosuppressed patients such as kidney transplant recipients (KTs) have increased mortality risk in the setting of coronavirus disease 2019 (COVID-19). The role and management of chronic immunosuppressive therapies during COVID-19 must be characterized. METHODS: Herein, we report the f...
שמור ב:
| הוצא לאור ב: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7929031/ https://ncbi.nlm.nih.gov/pubmed/34282376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab025 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|